ProShare Advisors’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$900K Buy
31,563
+2,128
+7% +$45.8K ﹤0.01% 830
2026
Q1
$338K Sell
29,435
-6,673
-18% -$94K ﹤0.01% 1282
2025
Q4
$519K Buy
36,108
+2,903
+9% +$50.2K ﹤0.01% 1117
2025
Q3
$629K Sell
33,205
-4,363
-12% -$71.9K ﹤0.01% 995
2025
Q2
$805K Sell
37,568
-6,674
-15% -$99.2K ﹤0.01% 894
2025
Q1
$580K Sell
44,242
-11,856
-21% -$176K ﹤0.01% 1010
2024
Q4
$754K Buy
56,098
+19,356
+53% +$312K ﹤0.01% 1038
2024
Q3
$779K Buy
36,742
+15,159
+70% +$273K ﹤0.01% 892
2024
Q2
$341K Sell
21,583
-7,367
-25% -$135K ﹤0.01% 1195
2024
Q1
$430K Buy
28,950
+2,842
+11% +$38.9K ﹤0.01% 1176
2023
Q4
$239K Buy
26,108
+6,012
+30% +$41.5K ﹤0.01% 1542
2023
Q3
$112K Sell
20,096
-23
-0.1% -$161 ﹤0.01% 1614
2023
Q2
$162K Buy
20,119
+5,916
+42% +$43.6K ﹤0.01% 1588
2023
Q1
$92.9K Sell
14,203
-1,323
-9% -$5.4K ﹤0.01% 1604
2022
Q4
$38.2K Buy
15,526
+2,503
+19% +$7.82K ﹤0.01% 1764
2022
Q3
$64K Sell
13,023
-249
-2% -$1.45K ﹤0.01% 1631
2022
Q2
$57K Buy
+13,272
New +$84.5K ﹤0.01% 1689

Other funds holding OSCR

ProShare Advisors's OSCR Position: Q2 2026 in Review

ProShare Advisors increased its Oscar Health (OSCR) stake by 7.2% in Q2 2026, buying an estimated $45.8K and bringing the position to 31,563 shares worth $900K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

ProShare Advisors first reported a position in OSCR in Q2 2022 and has held it in 17 quarters since. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • ProShare Advisors held 31,563 shares of Oscar Health worth $900K as of Q2 2026.
  • ProShare Advisors bought 2,128 Oscar Health shares in Q2 2026, an estimated $45.8K.
  • Oscar Health made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #830 holding.
  • ProShare Advisors first reported a position in Oscar Health in Q2 2022 and has held it in 17 quarters since.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.